学术探索
学术期刊
新闻热点
数据分析
智能评审

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

被引：40
作者：
Berglund, A. [1 ]
Cedermark, B. [2 ]
Glimelius, B. [1 ,3 ]
机构：
[1] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[2] Karolinska Inst, Dept Surg, S-10401 Stockholm, Sweden
[3] Karolinska Inst, Dept Oncol, S-10401 Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷 / 02期
关键词：
D O I：
10.1093/annonc/mdm582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：400 / 402
页数：3
相关论文
共 24 条
  • [1] AHMAD A, 2007, P AM SOC CLIN ONCO S, V25, pS177
  • [2] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2343 - 2351
  • [3] Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients:: Final results of GERCOR c96.1
    Andre, Thierry
    Quinaux, Emmanuel
    Louvet, Christophe
    Colin, Philippe
    Gamelin, Erik
    Bouche, Olivier
    Achille, Emmanuel
    Piedbois, Pascal
    Tubiana-Mathieu, Nicole
    Boutan-Laroze, Arnaud
    Flesch, Michel
    Lledo, Gerard
    Raoul, Yves
    Debrix, Isabelle
    Buyse, Marc
    de Gramont, Aimery
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3732 - 3738
  • [4] BIAGI JJ, 2007, AM SOC CLIN ONC GAST
  • [5] CARLSSON G, 2007, P AM SOC CLIN ONCO S, V25, pS177
  • [6] Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy
    Chan, AKP
    Wong, A
    Jenken, D
    Heine, J
    Buie, D
    Johnson, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03): : 665 - 677
  • [7] Adjuvant therapy in colon cancer - what, when and how?
    Chau, I.
    Cunningham, D.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (09) : 1347 - 1359
  • [8] A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer
    Chau, I
    Norman, AR
    Cunningham, D
    Tait, D
    Ross, PJ
    Iveson, T
    Hill, M
    Hickish, T
    Lofts, F
    Jodrell, D
    Webb, A
    Oates, JR
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (04) : 549 - 557
  • [9] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
    Gill, S
    Loprinzi, CL
    Sargent, DJ
    Thomé, SD
    Alberts, SR
    Haller, DG
    Benedetti, J
    Francini, G
    Shepherd, LE
    Seitz, JF
    Labianca, R
    Chen, W
    Cha, SS
    Heldebrant, MP
    Goldberg, RM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1797 - 1806
  • [10] Adjuvant chemotherapy in colorectal cancer:: A joint analysis of randomised trials by the Nordic gastrointestinal tumour adjuvant therapy group
    Glimelius, B
    Dahl, O
    Cedermark, B
    Jakobsen, A
    Bentzen, SM
    Starkhammar, H
    Grönberg, H
    Hultborn, R
    Albertsson, M
    Påhlman, L
    Tveit, KM
    [J]. ACTA ONCOLOGICA, 2005, 44 (08) : 904 - 912
123